DNA RNA and Cells
15 October 2015
RXi Pharmaceuticals Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-1097 October 2015
Ascend Announces Patients with Nodular Basal Cell Carcinoma Receives First Dose of ASN-002 in Phase 1/2a Study5 October 2015
Spark Therapeutics Announces Positive Top-line Results From Pivotal Phase 3 Trial of SPK-RPE65 for Genetic Blinding Conditions5 October 2015
Data from Ongoing Study of AVXS-101 in Spinal Muscular Atrophy Type 1 Presented at World Muscle Congress5 October 2015
SanBio Inc. Begins Recruiting Patients to Test Regenerative Treatment for Traumatic Brain Injury30 September 2015
Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease30 September 2015
Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure29 September 2015
BioMarin Enrolls First Patient in Phase 1/2 Trial of Gene Therapy Drug Candidate BMN 270 for the Treatment of Hemophilia A28 September 2015
Cellular Biomedicine Group Announces Positive Results From CAR-T EGFR Immunotherapy in Advanced Relapsed/Refractory Patients With Solid Tumors25 September 2015
Aurora BioPharma To Present Promising CAR T Cell Therapy Clinical Data in Glioblastoma at BIO Investor Forum25 September 2015
Microlin Bio, Inc. Announces Positive Results From Preclinical Lung Cancer Study Using Lead Anti-microRNA Candidate24 September 2015
Atara Bio’s T-Cell Product Candidate Activated Against Wilms’ Tumor 1 Protein Demonstrates Encouraging Results in Patients With Plasma Cell Leukemia23 September 2015
OncoGenex Announces Phase 2 Rainier Results in Previously Untreated Metastatic Pancreatic Cancer23 September 2015
TiGenix: AlloCSC-01 Phase I data Presented at the Congress of the European Society of Cardiology19 September 2015
Orgenesis Delivers Poster Presentation at European Society of Gene and Cell Therapy (ESGCT) Congress19 September 2015
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure’s Novel AAV5-Based Gene Therapy19 September 2015
AmpliPhi Announces Data Demonstrating Efficacy of a Novel Bacteriophage Cocktail is Comparable to Vancomycin in S. aureus Lung Infection ModelNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports